Detalhe da pesquisa
1.
Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism.
Am J Hum Genet
; 109(4): 553-570, 2022 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35202564
2.
Excess Growth Hormone Triggers Inflammation-Associated Arthropathy, Subchondral Bone Loss, and Arthralgia.
Am J Pathol
; 193(6): 829-842, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36870529
3.
High prevalence of severe sleep cycle disruption in de novo acromegaly and underdiagnosis by common clinical screening tools: A prospective, observational, cross-sectional study.
Clin Endocrinol (Oxf)
; 100(3): 251-259, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127470
4.
IGF-1 as screening tool for acromegaly and adult-onset growth hormone deficiency in the Netherlands.
Clin Endocrinol (Oxf)
; 100(3): 260-268, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38044875
5.
Pregnancy and acromegaly: clinical outcomes of retrospectively analysed data from the German acromegaly registry.
Reprod Biol Endocrinol
; 22(1): 48, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38650041
6.
Recurrent acromegaly: a systematic review on therapeutic approaches.
BMC Endocr Disord
; 24(1): 13, 2024 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279102
7.
Glucose intolerance in acromegaly is driven by low insulin secretion; results from an intravenous glucose tolerance test.
Pituitary
; 27(2): 178-186, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38381238
8.
Acromegaly increases depressive symptoms and reduces quality of life of cohabitants.
Pituitary
; 27(2): 169-177, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38159126
9.
The prevalence and associated risk factors of detectable renal morphological abnormalities in acromegaly.
Pituitary
; 27(1): 44-51, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38064149
10.
Consensus on criteria for acromegaly diagnosis and remission.
Pituitary
; 27(1): 7-22, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37923946
11.
Newer parameters of the octreotide test in patients with acromegaly.
Pituitary
; 27(1): 33-43, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37999819
12.
An international simulated-use study to assess nurses' preferences between two lanreotide syringes for patients with neuroendocrine tumours or acromegaly (PRESTO 3).
J Endocrinol Invest
; 47(2): 421-432, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37550552
13.
Paradoxical GH increase after oral glucose load in subjects with and without acromegaly.
J Endocrinol Invest
; 47(1): 213-221, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37344722
14.
Conventional X-rays in the diagnosis and follow-up of vertebral fractures in patients with acromegaly: a real-life study.
J Endocrinol Invest
; 47(2): 325-334, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37668886
15.
Erectile function and androgen and estrogen beta receptor gene polymorphisms in acromegalic men.
J Endocrinol Invest
; 47(1): 141-147, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37306894
16.
Pasireotide effects on biochemical control and glycometabolic profile in acromegaly patients switched from combination therapies or unconventional dosages of somatostatin analogs.
J Endocrinol Invest
; 47(3): 683-697, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37695461
17.
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype?
Int J Mol Sci
; 25(3)2024 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339173
18.
Pompe disease misdiagnosed as polymyositis.
Pract Neurol
; 24(1): 66-69, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37852755
19.
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies.
Semin Liver Dis
; 43(1): 24-30, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652958
20.
A cohort study found a high risk of end-stage kidney disease associated with acromegaly.
Kidney Int
; 104(4): 820-827, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37490954